AR and prostate cancer: Interestingly, activity of these enzyme results strongly linked the tumorigenic potential of androgen receptor (AR)-expressing cancer cells (Vatapalli et al., 2020), in line with the known involvement of this HMT in AR signaling in prostate cancer cells (Yang et al., 2013).